Skip to main content

Atlas Venture Associates IX, LLC

Location
BOSTON, MA
Portfolio Value
Micro $5,914,268
Diversification
Highly concentrated
Filing Date
Global Rank
#6,655 / 6,900 ▲ 52 · as of Sep 2023
Top Industry
Biotechnology 77.4%
3Y Alpha vs SPY
-25.1%
Period ended 2 years ago
Filed Nov 13, 2023 · 2y
15 quarters · since Mar 2020

Clone Performance

Jul 2023–Jul 2026 · vs SPY

Hypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.

Cloned portfolio
-10.0%
SPY
+76.0%
Annualised alpha
-24.2%
Max drawdown
−69.2%

Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.

Portfolio Concentration

5 positions · as of Sep 30, 2023 · Δ vs Jun 30, 2023
Top Position
35.9%
−11.4 pts
Top 5
100.0%
0.0 pts
Top 10
100.0%
0.0 pts
HHI
2,669
Dec 2020 → Sep 2023 · range 2,669 – 5,408
Highly concentrated−1,502

Portfolio Trend

15 quarters · across all stocks

Sector Breakdown

As of Sep 30, 2023
Sector % Portfolio Value
Healthcare 77.4% $4,576,343
Communication Services 22.6% $1,337,925

Last Quarter's Activity

Export CSV
Sep 30, 2023 vs Jun 30, 2023

Added To

Positions the filer increased
No qualifying positions this quarter.

Trimmed

Positions the filer reduced
No qualifying positions this quarter.

New Positions

Positions the filer opened this quarter
2 positions
Ticker Shares Value Open

Sold Out

Positions the filer fully exited
No qualifying positions this quarter.

Portfolio Positions

Export CSV View 13F filing
5 positions · $5,914,268 total · as of Sep 30, 2023
Ticker Company Shares Value (USD) % of Portfolio History